September 10, 2025Breast Cancer Targets and TherapyOpen Access

Late Breast Cancer Recurrence Prediction: The Role of CTS5 and Progesterone Receptor Status

View Full Paper

Ask AI

Bookmark

Late recurrence rates were significantly influenced by progesterone receptor status, showing that it is a key prognostic factor.
The analysis of 162 patients revealed a 10-year Disease Free-Survival rate of 100% for low risk and 68.2% for high risk groups.
Retrospective data from a national cancer center indicated that CTS5 is effective in predicting late recurrences, especially in high-risk populations.
Findings suggest that progesterone receptor status should be part of future prospective studies to better understand its impact on breast cancer prognosis.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective analysis found that CTS5 and progesterone receptor status predict recurrence in HR-positive breast cancer, suggesting a need for closer monitoring.

Cite This Study

Carvalho et al. (2025) studied this question.

synapsesocial.com/papers/68c2409bb210217d6479b0c0 https://doi.org/10.2147/bctt.s512760

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis found that CTS5 and progesterone receptor status predict recurrence in HR-positive breast cancer, suggesting a need for closer monitoring.

Late Breast Cancer Recurrence Prediction: The Role of CTS5 and Progesterone Receptor Status

Key Points

Discussion

Implication

Cite This Study

Late Breast Cancer Recurrence Prediction: The Role of CTS5 and Progesterone Receptor Status

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider